MSLN and familial pancreatic carcinoma: ,71 Although the prognostic role of MSLN in patients with ovarian and gastric cancers remains controversial, data derived from pancreatic cancer studies consistently indicate that high MSLN expression portends an unfavorable prognosis for patients.